Acute rejection (AR) of human hand allografts (HHAs) may carry a risk of graft loss and leads
to the need for immunosuppressive treatment. The literature on HHAs was reviewed to …

Background. The envelope glycoprotein gB of human cytomegalovirus (CMV) occurs as one
of four main genotypes. Some previous studies have proposed a relationship of CMV gB …

Human cytomegalovirus (HCMV) infection is the single most frequent infectious complication
in the early period after kidney transplantation. The HCMV load in blood, measured by …

Background Cytomegalovirus (CMV) remains a significant contributor to morbidity and
mortality following solid organ transplantation (SOT). While recurrent infection occurs in up …

The aim of this prospective randomized trial was to study the efficacy and safety of
tacrolimus monotherapy (TACRO) and compare it with our standard treatment of tacrolimus …

Background. The impact of advanced donor age on hepatic artery thrombosis (HAT) after
liver transplantation (LT) is controversial. Methods. We analyzed the incidence of and risk …

Studies of the immune mechanisms of allograft rejection have predominantly focused on the
adaptive immune system that includes T cells and B cells. Recent investigations into the …

Background. With the development of sensitive tests to detect cytomegalovirus (CMV)
viremia, preemptive approaches become a reasonable alternative to general CMV …

With improved cytomegalovirus (CMV) prophylaxis, CMV disease after liver transplantation
has decreased dramatically, and patient and graft survival have improved. We examined the …

A cytomegalovirus (CMV) donor positive/recipient negative liver transplant recipient
developed CMV syndrome with presumed colitis 2 weeks after discontinuing the standard 3 …